Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 07 Jan 2026 for Biohaven Ltd..
Insider track record
Disclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kimberly Gentile: trading record in brief
Kimberly Gentile, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Biohaven Pharmaceutical Holding Co Ltd. and Biohaven Ltd. Over a trading history stretching from 1 November 2017 to 5 January 2026, the count stands at 66 filings.
On the market, this insider has only sold: 20 sales, €5.3M in total. Besides market trades, the filings include 8 share grants and 33 option exercises.
The newest entry dates from 7 January 2026: a share grant of €17k, in Biohaven Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kimberly Gentile
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,750 shares0Common SharesSEC:0001704186-26-000002:0
3,750 shares0Common SharesSEC:0001935979-25-000005:0
5,826 shares0Common SharesSEC:0001562180-22-007085:0
11,653 shares@ US$148.50100.0% of flowCommon SharesSEC:0001562180-22-006949:0
3,750 shares0Common SharesSEC:0001562180-22-000354:0
3,750 shares0Common SharesSEC:0001562180-21-007301:0
6 of 6 declarations
